Opportunity

Manager, Market Access

TB Alliance New York, United States
Sidney Moss
Role managed by
Sidney Moss

About the TB Alliance


TB Alliance is an international product development partnership (PDP) created to accelerate the development and adoption of urgently needed new anti-tuberculosis (TB) drugs. As a not-for-profit organization, TB Alliance functions through strategic relationships with pharmaceutical companies, academic institutions, research labs, and governmental agencies, and deploys preferred service providers for contract research. Based in New York City, TB Alliance also operates a satellite office in Pretoria, South Africa, focused on clinical trials management.

TB Alliance is preeminent in the TB drug development field and is pursuing faster, simpler treatments for all forms of TB through the innovative PDP business model that bridges the expertise and functionality of industry with academic and public-sector interests to meet a major unmet global health need.

With an annual operating budget of approximately $60 million, TB Alliance leads the advancement of the most comprehensive R&D portfolio of TB drug candidates in history. Currently, a portfolio of more than 20 projects spans from target validation to Phase III clinical development. Additionally, TB Alliance drives efforts to ensure regulatory approval, country adoption of new regimens, and widespread availability of new drug regimens to patients.

Tuberculosis kills nearly 1.5 million each year. Yet, current treatments are antiquated, inadequate, and excessively burdensome. Long, demanding treatment schedules prove too much for many patients, leading to the emergence of multi- and extensively- drug-resistant TB (MDR-TB and XDR-TB), which are exponentially more expensive and difficult to treat.

You can find further details on their website www.tballiance.org.

Meet current CEO: Dr. Melvin Spigelman.

This role holds a unique opportunity: To prioritize in low- and middle-income countries, especially those with high incidence of tuberculosis, the access of a new pretomanid-containing treatment: BPaL. “FDA approval of this treatment represents a victory for the people suffering from these highly drug-resistant forms of the world’s deadliest infectious disease.” - Mel Spigelman

 

Manager, Market Access


The Manager, Market Access will be responsible for global and country market research, market intelligence, monitoring & impact measurement, forecasting, and managing select country relationships.

The role is broad in scope, with involvement in both the pediatric and adult markets, both demand and supply side initiatives, public health and the private sector markets and scope of the work will be at global as well country level. The role will contribute significantly to rapid introduction and broad access to novel TB treatments, developed by TB Alliance.

The Market Access function at the TB Alliance includes all elements on the value chain including supplier relationship management, pricing strategy, forecasting, market understanding, resource mobilization, support for policy change, regulatory issues, diagnostics as well as technical adoption-related issues.

The opening is happening at an exciting time for new TB regimens. Regulatory approval for a novel, short, all-oral regimen for XDR-TB has recently been obtained, and work is ongoing to support planning for a forthcoming short regimen for both DS and MDR-TB.

The position reports to the Vice President Market Access of TB Alliance.

Duties and Responsibilities

The Manager, Market Access will have the following key responsibilities:

  • Keep abreast of market trends and developments in the field of TB and ensure TB Alliance has contemporary and in-depth market intelligence and understanding of the TB market and sub-segments, to help guide strategies for adoption and uptake of new TB regimens

  • Design, guide and coordinate market research to support and inform policy development, global, regional and country launch planning and market uptake initiatives

  • Develop forecasts for TB medicines and regimens in collaboration with global stakeholders

  • Monitor, measure and report uptake of medicines and regimens developed by TB Alliance, and impact created by them

  • Provide guidance into market analytics and data to help inform development of novel TB treatments

  • Manage select country relationships and guide implementation of strategy in close coordination with commercial partners

  • Help develop strategies and interventions for select target countries to support access, availability and adoption of forthcoming TB regimens

  • Responsible for compliance with applicable GxP regulations in performing the functions of the job, including attendance at annual GxP or other applicable regulatory trainings provided by TB Alliance.

Qualifications and Experience

  • A minimum of 5 years’ professional experience in the following: access to medicines, product introduction, market research, monitoring & evaluation in global health, and forecasting with focus on developing countries

  • Experience of working with global health stakeholders as well as the pharmaceutical industry is desirable

  • Working knowledge of current TB treatment landscape in TB endemic countries highly preferred

  • Experience designing primary qualitative and quantitative market research, selecting, commissioning, and overseeing externally conducted research, and experience with resourceful utilization of secondary research to solve challenging business or public health issues

  • Relevant educational background; MBA, MPH or other relevant advanced degree

  • Demonstrated ability to rapidly adjust to and take on new areas, and to absorb and synthesize a broad range of information, especially clinical and scientific information

  • Ability to think strategically, handle ambiguity, problem solve

  • Excellent project management, communication and analytical skills

  • Commitment to global health and neglected diseases, specifically TB.

Terms of Appointment

  • This is a full-time position. The position will be ideally based in New York, USA.

  • TB Alliance is an equal employment opportunity employer and is committed to maintaining a non-discriminatory work environment. TB Alliance is committed to creating a dynamic work environment that values diversity and inclusion, respect and integrity, customer focus, and innovation.

How to Apply

If you wish to be considered for this position, please forward a copy of your CV in Microsoft Word format, along with any additional relevant documentation to Ms. Sidney Moss at [email protected] or use the Application Form below on or before March 5, 2020. All information will be treated in the strictest confidence as we pride ourselves on our professional service. We will revert to you as soon as feasible when we have reviewed your application.

SRI Executive is exclusively retained by TB Alliance to undertake this assignment.

Application form